John Ryan

Insider Reports History

Entity
Individual
Location
C/O Kadmon Holdings, Llc, 450 E. 29 Th Street, New York, NY
Signature
/s/ John Ryan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Ryan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Unicycive Therapeutics, Inc. Director Stock Options 124K Sep 5, 2023 Direct
Kadmon Holdings, Inc. EVP, Chief Medical Officer Equity Appreciation Rights Unit 0 $3.50 Nov 9, 2021 Direct
Kadmon Holdings, Inc. EVP, Chief Medical Officer Stock Option (right to buy) 0 $5.54 Nov 9, 2021 Direct

Insider Reports Filed by John Ryan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
UNCY Unicycive Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 Director
KDMN Kadmon Holdings, Inc. Nov 9, 2021 6 -$3.2M 4 Nov 9, 2021 EVP, Chief Medical Officer
UNCY Unicycive Therapeutics, Inc. Jul 12, 2021 0 $0 3 Jul 12, 2021 Director